SCHEMBL7919616

SCHEMBL7919616

CN1CCc2cc(Cl)c(O)cc2C(c2ccccc2F)C1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 13/20 0.77
DRD5 P21918 5/20 0.72
DRD2 P14416 4/20 0.72
CYP1A2 P05177 2/20 0.72
CYP2D6 P10635 2/20 0.72
TSHR P16473 2/20 0.72
HSD17B10 Q99714 2/20 0.72
CYP3A4 P08684 1/20 0.72
NFKB1 P19838 1/20 0.72
THPO P40225 1/20 0.72
MEN1 O00255 1/20 0.72
ALOX15 P16050 1/20 0.72
KMT2A Q03164 1/20 0.72
SIGMAR1 Q99720 1/20 0.72
LMNA P02545 1/20 0.71
ADRB2 P07550 1/20 0.71
GPR183 P32249 1/20 0.71
APLNR P35414 1/20 0.71
GLP1R P43220 1/20 0.71
CX3CR1 P49238 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14502337 0.87 DRD1 (1.00) DRD1DRD5DRD2CYP1A2CYP2D6
SCHEMBL13900337 0.86 DRD1 (0.82) DRD1DRD5DRD2CYP1A2CYP2D6
Sch-23390 SCHEMBL11107859 0.84 DRD1 (1.00) DRD1DRD5DRD2CYP1A2CYP2D6
Sch-23390 SCHEMBL30628012 0.84 DRD1 (1.00) DRD1DRD5DRD2CYP1A2CYP2D6
Sch-23390 SCHEMBL29431888 0.84 DRD1 (1.00) DRD1DRD5DRD2CYP1A2CYP2D6
Sch-23390 SCHEMBL2916216 0.84 DRD1 (1.00) DRD1DRD5DRD2CYP1A2CYP2D6
Sch-23390 SCHEMBL29424268 0.84 DRD1 (1.00) DRD1DRD5DRD2CYP1A2CYP2D6
Sch-23390 SCHEMBL16187032 0.84 DRD1 (1.00) DRD1DRD5DRD2CYP1A2CYP2D6
Sch-23390 SCHEMBL29797998 0.84 DRD1 (1.00) DRD1DRD5DRD2CYP1A2CYP2D6
Sch-23390 SCHEMBL5722114 0.84 DRD1 (1.00) DRD1DRD5DRD2CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211173-B1 Use of 2,3,4,5-tetrahydro-1H-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders CENES LIMITED (GB) 2001-04-03 US disclosed
EP-1011679-A1 USE OF 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SLEEP DISORDERS CeNes Limited (GB) 2000-06-28 EP disclosed
WO-1998040072-A1 USE OF 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SLEEP DISORDERS CENES LIMITED (GB) 1998-09-17 WO disclosed
EP-0347672-B1 Benzazepine derivatives NOVO NORDISK AS (DK) 1994-03-02 EP disclosed
US-5025009-A Treatment of central nervous system disorders; bioavailability NOVO NORDISK A/S (DK) 1991-06-18 US disclosed
US-5010074-A Treating CNS disorders; dopamine antagonist; bioavailability NOVO NORDISK A/S (DK) 1991-04-23 US disclosed
EP-0347672-A1 Benzazepine derivatives NOVO NORDISK A/S (DK) 1989-12-27 EP disclosed